Investing.com - Imunon reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Imunon announced earnings per share of $-0.8700 on revenue of $125K. Analysts polled by Investing.com anticipated EPS of $-0.8100 on revenue of $100K.
Imunon shares are down 67% from the beginning of the year, still down 88.69% from its 52 week high of $13.05 set on November 15, 2021.
Imunon shares lost 2.27% in intra-day trade following the report.
Imunon follows other major Healthcare sector earnings this month
Imunon's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar